Create
Log in
Sign up
Golden has been acquired by ComplyAdvantage.
Read about it here ⟶
US Patent 11780921 Antibodies to programmed cell death protein 1
Overview
Structured Data
Issues
Contributors
Activity
Access by API
Access by API
Is a
Patent
Date Filed
March 23, 2021
Date of Patent
October 10, 2023
Patent Application Number
17210117
Patent Citations
US Patent 11021540 Antibodies to programmed cell death protein 1
US Patent 10428146 Anti PD-1 antibodies
US Patent 10897541 Conference call platform capable of generating engagement scores
US Patent 8043620 Wise binding agents and epitopes
US Patent 8481687 Anti-ErbB3 antibodies
US Patent 8552154 Anti-PD-L1 antibodies and uses therefor
US Patent 9109025 Anti-RSPO2 antibodies
US Patent 9127071 Anti-DLL3 antibody
US Patent 9987500 Human antibodies to PD-1
US Patent 10155037 Anti-PD-1 antibodies and methods of use thereof
Patent Inventor Names
Mikayel Mkrtichyan
Samir Khleif
Patent Jurisdiction
United States Patent and Trademark Office
Patent Number
11780921
Patent Primary Examiner
Amy E Juedes
CPC Code
A61P 35/00
C07K 16/2818
Find more entities like US Patent 11780921 Antibodies to programmed cell death protein 1
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Company
Home
Press & Media
Blog
Careers
WE'RE HIRING
Products
Knowledge Graph
Query Tool
Data Requests
Knowledge Storage
API
Pricing
Enterprise
ChatGPT Plugin
Legal
Terms of Service
Enterprise Terms of Service
Privacy Policy
Help
Help center
API Documentation
Contact Us
SUBSCRIBE